Literature DB >> 26834961

Risk of intracranial hypertension with intrauterine levonorgestrel: reply.

Mahyar Etminan1.   

Abstract

Entities:  

Year:  2016        PMID： 26834961      PMCID： PMC4716392          DOI： 10.1177/2042098615621264

Source DB:  PubMed          Journal:  Ther Adv Drug Saf        ISSN： 2042-0986


× No keyword cloud information.
  6 in total

1.  OpenVigil--free eyeballs on AERS pharmacovigilance data.

Authors:  Ruwen Böhm; Jan Höcker; Ingolf Cascorbi; Thomas Herdegen
Journal:  Nat Biotechnol       Date:  2012-02-08       Impact factor: 54.908

2.  Risk of intracranial hypertension with intrauterine levonorgestrel.

Authors:  Mahyar Etminan; Hao Luo; Paul Gustafson
Journal:  Ther Adv Drug Saf       Date:  2015-06

3.  Sensitivity analysis and external adjustment for unmeasured confounders in epidemiologic database studies of therapeutics.

Authors:  Sebastian Schneeweiss
Journal:  Pharmacoepidemiol Drug Saf       Date:  2006-05       Impact factor: 2.890

4.  The search for causes of idiopathic intracranial hypertension. A preliminary case-control study.

Authors:  B Ireland; J J Corbett; R B Wallace
Journal:  Arch Neurol       Date:  1990-03

5.  Pharmacokinetic and pharmacodynamic studies of levonorgestrel-releasing intrauterine device.

Authors:  B L Xiao; L Y Zhou; X L Zhang; M C Jia; T Luukkainen; H Allonen
Journal:  Contraception       Date:  1990-04       Impact factor: 3.375

6.  Epidemiology of idiopathic intracranial hypertension: a prospective and case-control study.

Authors:  K Radhakrishnan; A K Thacker; N H Bohlaga; J C Maloo; S E Gerryo
Journal:  J Neurol Sci       Date:  1993-05       Impact factor: 3.181
  6 in total
  1 in total

1.  Revised disproportionality analysis of Mirena and benign intracranial hypertension.

Authors:  Mahyar Etminan
Journal:  Ther Adv Drug Saf       Date:  2017-06-22
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.